Yuval Cohen - Net Worth and Insider Trading
Yuval Cohen Net Worth
The estimated net worth of Yuval Cohen is at least $109,679 dollars as of 2024-04-25. Yuval Cohen is the CEO of Corbus Pharmaceuticals Holdings Inc and owns about 3,274 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $109,679. Details can be seen in Yuval Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yuval Cohen has not made any transactions after 2022-08-10 and currently still holds the listed stock(s).
Transaction Summary of Yuval Cohen
Yuval Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yuval Cohen owns 1 companies in total, including Corbus Pharmaceuticals Holdings Inc () .
Click here to see the complete history of Yuval Cohen’s form 4 insider trades.
Insider Ownership Summary of Yuval Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | 2022-08-10 | director & Chief Executive Officer |
Yuval Cohen Latest Holdings Summary
Yuval Cohen currently owns a total of 1 stock. Yuval Cohen owns 3,274 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of August 10, 2022, with a value of $109,679.
Latest Holdings of Yuval Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2022-08-10 | 3,274 | 33.50 | 109,679 |
Holding Weightings of Yuval Cohen
Yuval Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Yuval Cohen has made a total of 8 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 127 shares on August 10, 2022, which cost Yuval Cohen around $988.
Insider Trading History of Yuval Cohen
- 1
Yuval Cohen Trading Performance
GuruFocus tracks the stock performance after each of Yuval Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yuval Cohen is 6.34%. GuruFocus also compares Yuval Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yuval Cohen within 3 months outperforms 8 times out of 23 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yuval Cohen's insider trading performs compared to the benchmark.
Performance of Yuval Cohen
Average Return
32.24%
Outperforming Transactions
43%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.48 | 6.34 | 3.06 | 32.24 | 9.52 | -12.3 |
| Relative Return to S&P 500(%) | 0.25 | 2.96 | -1.88 | 21.02 | -3.21 | -23.83 |
Yuval Cohen Ownership Network
Ownership Network List of Yuval Cohen
Ownership Network Relation of Yuval Cohen
Yuval Cohen Owned Company Details
What does Corbus Pharmaceuticals Holdings Inc do?
Who are the key executives at Corbus Pharmaceuticals Holdings Inc?
Yuval Cohen is the director & Chief Executive Officer of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , Chief Commercial Officer Craig Stuart Millian , and Chief Scientific Officer Rachael Louise Brake .
Corbus Pharmaceuticals Holdings Inc () Insider Trades Summary
Over the past 18 months, Yuval Cohen made no insider transaction in Corbus Pharmaceuticals Holdings Inc (). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc () include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , and a net purchase of 550,000 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc () in total and bought 1,582,632 shares, with a net purchase of 1,582,632 shares. During the past 18 months, 0 shares of Corbus Pharmaceuticals Holdings Inc () were sold and 1,582,632 shares were bought by its insiders, resulting in a net purchase of 1,582,632 shares.
Corbus Pharmaceuticals Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Corbus Pharmaceuticals Holdings Inc Insider Transactions
Yuval Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Yuval Cohen. You might contact Yuval Cohen via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood Ma 02062.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
